13F filer · CIK 902219 ↗
Wellington Management Group LLP
You are looking at Q4 2024. See the latest, Q2 2026 →
Reported value
$546.18B
−4.3% on the quarter before
Positions
1,927
172 new · 155 sold out
Top 10
25.3%
of the value
Est. gain
−$559.1M
on stocks held all quarter
Est. return
−0.1%
on those stocks since Q3 2024
Positions as of Dec 31, 2024, from Wellington Management Group LLP's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 37% of the reported value, each sized by its share, colored by what the fund did with it since Q3 2024. Striped tiles are options.
Largest buys
Since Q3 2024, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Alphabet~$1.71BAdded · 1.7% → 2.3%+9,042,271 shares
- Eli Lilly~$1.55BAdded · 1.6% → 1.8%+2,012,129 shares
- Arista Networks~$1.22BNew · 0.0% → 0.2%+11,013,511 shares
- Tesla~$1.14BAdded · 0.3% → 0.8%+2,829,609 shares
- Boeing Co~$934.8MAdded · 0.1% → 0.2%+5,281,192 shares
- Te Connectivity Plc~$909.6MNew · 0.0% → 0.2%+6,362,160 shares
- Jabil~$834.7MAdded · 0.0% → 0.2%+5,800,535 shares
- Bank America Corp~$822.1MAdded · 0.3% → 0.5%+18,705,125 shares
- Accenture Plc Ireland~$795.3MAdded · 0.6% → 0.8%+2,260,740 shares
- Elevance Health Inc~$698.7MAdded · 0.4% → 0.4%+1,893,947 shares
Largest sells
Since Q3 2024, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Apple~$1.79BCut · 3.9% → 4.1%−7,144,852 shares
- Visa Inc.~$1.57BCut · 0.7% → 0.5%−4,977,997 shares
- General Dynamics Corp~$1.55BCut · 0.8% → 0.4%−5,898,862 shares
- Morgan Stanley~$1.29BCut · 0.6% → 0.5%−10,275,782 shares
- Exelon Corporation~$1.15BCut · 0.5% → 0.2%−30,570,932 shares
- Arista Networks~$1.02BSold out · 0.2% → 0.0%−2,660,695 shares
- Eqt Corp~$959.6MCut · 0.5% → 0.5%−20,810,907 shares
- Amazon~$874.7MCut · 2.3% → 2.7%−3,987,132 shares
- Progressive Corp~$796.5MCut · 0.4% → 0.3%−3,324,110 shares
- Honeywell Technologies~$760.8MCut · 0.6% → 0.6%−3,367,886 shares
Holdings
As of Dec 31, 2024. Changes are in shares against Sep 30, 2024, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AppleCOM · shares −7.4% · price +7.5% | 4.1% | $22.35B | +$1.55B | ||||||||
| MicrosoftCOM · shares −2.0% · price −2.0% | 4.1% | $22.34B | −$466.3M | ||||||||
| NvidiaCOM · shares −3.2% · price +10.6% | 3.5% | $19.05B | +$1.82B | ||||||||
| AmazonCOM · shares −5.7% · price +17.7% | 2.7% | $14.56B | +$2.19B | ||||||||
| AlphabetCAP STK CL A · shares +16% · price +14.1% | 2.3% | $12.50B | +$1.34B | ||||||||
| Unitedhealth Group IncCOM · shares −6.0% · price −13.5% | 2.2% | $11.82B | −$1.84B | ||||||||
| BroadcomCOM · shares −6.3% · price +34.4% | 2.0% | $10.78B | +$2.76B | ||||||||
| Eli LillyCOM · shares +19% · price −12.9% | 1.8% | $9.75B | −$1.21B | ||||||||
| Merck & Co IncCOM · shares +6.5% · price −12.4% | 1.5% | $8.03B | −$1.07B | ||||||||
| Jpmorgan Chase & Co.COM · shares −1.6% · price +13.7% | 1.3% | $7.03B | +$846.2M | ||||||||
| Wells Fargo Co NewCOM · shares −4.3% · price +24.3% | 1.1% | $6.13B | +$1.20B | ||||||||
| MetaCL A · shares −8.8% · price +2.3% | 1.0% | $5.73B | +$128.0M | ||||||||
| MastercardCL A · shares +9.1% · price +6.6% | 0.94% | $5.14B | +$293.1M | ||||||||
| Danaher CorporationCOM · shares −8.5% · price −17.4% | 0.90% | $4.89B | −$1.03B | ||||||||
| American Express CoCOM · shares −1.3% · price +9.4% | 0.86% | $4.71B | +$405.8M | ||||||||
| AlphabetCAP STK CL C · shares −0.03% · price +13.9% | 0.80% | $4.39B | +$535.6M | ||||||||
| Accenture Plc IrelandSHS CLASS A · shares +23% · price −0.5% | 0.78% | $4.28B | −$16.8M | ||||||||
| Tjx Cos Inc NewCOM · shares −7.6% · price +2.8% | 0.77% | $4.21B | +$113.9M | ||||||||
| TeslaCOM · shares +39% · price +54.4% | 0.75% | $4.11B | +$1.04B | ||||||||
| Mcdonalds CorpCOM · shares −7.1% · price −4.8% | 0.74% | $4.06B | −$204.9M | ||||||||
| Procter And Gamble CoCOM · shares −10% · price −3.2% | 0.74% | $4.06B | −$134.5M | ||||||||
| Texas InstrumentsCOM · shares −5.3% · price −9.2% | 0.72% | $3.92B | −$398.0M | ||||||||
| S&P Global IncCOM · shares −12% · price −3.6% | 0.71% | $3.88B | −$144.8M | ||||||||
| NetflixCOM · shares −13% · price +25.7% | 0.69% | $3.78B | +$771.3M | ||||||||
| Pfizer IncCOM · shares −14% · price −8.3% | 0.68% | $3.71B | −$337.4M | ||||||||
| Total · 1,927 positions | 100% | $546.18B | −$559.1M |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q3 2024 to Q4 2024: 1,647 stocks held throughout, down $559.1M (−0.1%).
- Broadcom+$2.76B+34%
- Amazon+$2.19B+18%
- Nvidia+$1.82B+11%
- Apple+$1.55B+7%
- Alphabet+$1.34B+14%
- Hca Healthcare Inc−$686.8M−26%
- Danaher Corporation−$1.03B−17%
- Merck & Co Inc−$1.07B−12%
- Eli Lilly−$1.21B−13%
- Unitedhealth Group Inc−$1.84B−13%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 6 splits read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 14, 2026 | $580.17B+8% | SEC ↗ |
| Q1 2026 | May 15, 2026 | $535.46B−6% | SEC ↗ |
| Q4 2025 | Feb 17, 2026 | $570.66B−0% | SEC ↗ |
| Q3 2025 | Nov 14, 2025 | $571.31B+4% | SEC ↗ |
| Q2 2025 | Aug 14, 2025 | $550.98B+6% | SEC ↗ |
| Q1 2025 | May 13, 2025 | $519.87B−5% | SEC ↗ |
| Q4 2024 | Feb 12, 2025 (amended) | $546.18B−4% | SEC ↗ |
| Q3 2024 | Nov 14, 2024 | $570.97B+2% | SEC ↗ |
| Q2 2024 | Aug 14, 2024 | $560.18B−1% | SEC ↗ |
| Q1 2024 | May 15, 2024 | $564.44B+5% | SEC ↗ |
| Q4 2023 | Feb 12, 2024 (amended) | $536.37B+7% | SEC ↗ |
| Q3 2023 | Nov 14, 2023 (amended) | $499.52B−5% | SEC ↗ |
| Q2 2023 | Aug 14, 2023 | $527.49B+5% | SEC ↗ |
| Q1 2023 | May 12, 2023 | $504.61B+1% | SEC ↗ |
| Q4 2022 | Feb 13, 2023 | $498.70B+6% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $469.49B−5% | SEC ↗ |
| Q2 2022 | Aug 15, 2022 | $496.55B−15% | SEC ↗ |
| Q1 2022 | May 16, 2022 | $583.99B−7% | SEC ↗ |
| Q4 2021 | Feb 11, 2022 | $625.28B+6% | SEC ↗ |
| Q3 2021 | Nov 15, 2021 | $587.95B−2% | SEC ↗ |
| Q2 2021 | Aug 16, 2021 | $600.78B+6% | SEC ↗ |
| Q1 2021 | May 17, 2021 | $567.83B+5% | SEC ↗ |
| Q4 2020 | Feb 12, 2021 | $543.08B+12% | SEC ↗ |
| Q3 2020 | Nov 16, 2020 | $483.12B+8% | SEC ↗ |
| Q2 2020 | Aug 14, 2020 | $449.13B+19% | SEC ↗ |
| Q1 2020 | May 14, 2020 | $377.87B−21% | SEC ↗ |
| Q4 2019 | Feb 11, 2020 | $477.16B+8% | SEC ↗ |
| Q3 2019 | Nov 13, 2019 | $443.46B−2% | SEC ↗ |
| Q2 2019 | Aug 14, 2019 | $451.69B+2% | SEC ↗ |
| Q1 2019 | May 15, 2019 | $441.54B+11% | SEC ↗ |
| Q4 2018 | Feb 14, 2019 | $399.54B−16% | SEC ↗ |
| Q3 2018 | Nov 14, 2018 | $474.88B+6% | SEC ↗ |
| Q2 2018 | Aug 14, 2018 | $449.23B+2% | SEC ↗ |
| Q1 2018 | May 15, 2018 | $441.92B−2% | SEC ↗ |
| Q4 2017 | Feb 13, 2018 | $452.59B+4% | SEC ↗ |
| Q3 2017 | Nov 13, 2017 | $435.63B+3% | SEC ↗ |
| Q2 2017 | Aug 14, 2017 | $424.69B+2% | SEC ↗ |
| Q1 2017 | May 11, 2017 | $415.20B+4% | SEC ↗ |
| Q4 2016 | Feb 14, 2017 | $398.65B−0% | SEC ↗ |
| Q3 2016 | Nov 14, 2016 | $399.22B+3% | SEC ↗ |
| Q2 2016 | Aug 15, 2016 | $386.87B+2% | SEC ↗ |
| Q1 2016 | May 13, 2016 | $379.99B | SEC ↗ |